Treatment Overview
Advanced EVO ICL Vision Correction in Korea represents the most sophisticated form of Implantable Collamer Lens (ICL) surgery, offering a permanent yet reversible solution for patients who are not ideal candidates for laser procedures such as LASIK or SMILE.
Instead of reshaping the cornea, the EVO ICL involves implanting a soft, biocompatible collamer lens inside the eye, between the iris and the natural lens. This design preserves corneal structure while providing crystal-clear, high-definition vision for patients with moderate to severe myopia, astigmatism, or thin corneas.
Korea’s leading eye centers employ AI-assisted diagnostics, 3D anterior chamber mapping, and precision micro-incision implantation systems, offering one of the safest and most effective refractive correction options available worldwide.
Purpose & Benefits
Purpose
- Correct high myopia and astigmatism without removing corneal tissue.
- Provide a reversible, non-laser alternative for patients unsuitable for LASIK or SMILE.
- Preserve corneal integrity, ensuring long-term ocular health.
- Offer predictable, stable, and high-quality vision with minimal downtime.
Benefits
- Blade-Free & Tissue-Preserving: No corneal flap or ablation.
- Reversible & Upgradeable: The ICL can be safely replaced if prescription changes.
- Superior Visual Quality: Exceptional contrast sensitivity and night vision.
- Rapid Recovery: Functional vision within 24–48 hours.
- Comfort & Safety: Hydrophilic collamer lens material is biocompatible and UV-protective.
- Ideal for Thin Corneas: Suitable for patients not eligible for laser surgery.
Ideal Candidates
Advanced EVO ICL Vision Correction in Korea is ideal for:
- Adults aged 18 or older with a stable prescription for at least one year.
- Individuals with moderate to severe myopia (–3.00D to –20.00D) or astigmatism (up to –4.00D).
- Patients with thin corneas or dry-eye conditions unsuitable for laser correction.
- Those seeking a reversible, minimally invasive vision correction option.
- Patients who prefer a natural-feeling, high-definition vision experience.
Possible Risks & Complications
Although EVO ICL is considered one of the safest refractive surgeries available, mild and manageable side effects can occur:
- Temporary Light Sensitivity or Glare: Usually subsides within a few days.
- Increased Intraocular Pressure (IOP): Monitored and managed during follow-up visits.
- Lens Vault Adjustments: Rarely needed to optimize lens position.
- Mild Inflammation: Controlled with post-operative medications.
- Endothelial Cell Reduction: Rare with modern ICL models and precise Korean surgical standards.
Korean clinics minimize risks using high-frequency imaging, AI depth analysis, and strict sterilization protocols throughout the procedure.
Techniques & Technology Used
Core Techniques
- EVO/Visian Collamer Lens Technology: Flexible, biocompatible material designed for natural eye function.
- AI-Guided Preoperative Analysis: Measures anterior chamber depth, corneal curvature, and vault spacing.
- Micro-Incision Lens Insertion: Lens folded and inserted through a 2.8–3.2 mm incision.
- Precision Lens Positioning: Surgeon places the ICL behind the iris for optimal light refraction.
- Vault Optimization: Ensures safe distance between the ICL and natural lens to prevent cataract formation.
- Real-Time Intraoperative Imaging: Confirms accurate lens placement during surgery.
Korean ophthalmology centers use EVO+ ICL systems integrated with AI biometric scanners and femtosecond-assisted micro-implantation, ensuring unmatched accuracy and patient comfort.
Treatment Process in Korea
Step-by-Step Workflow
- Comprehensive Eye Evaluation:
Includes topography, anterior chamber measurement, corneal thickness, and endothelial cell analysis. - Customized Lens Planning:
Advanced software determines lens size, power, and vault parameters for each eye. - Lens Implantation Procedure:
- Topical anesthetic applied (no general anesthesia required).
- A small corneal incision is made for lens insertion.
- The folded ICL is gently positioned behind the iris and in front of the natural lens.
- Immediate Vision Check:
Surgeon confirms proper placement and clear vision before discharge. - Follow-Up Examinations:
Conducted at 1 day, 1 week, and 1 month to monitor vault and clarity.
Procedure Duration: 15–30 minutes per eye
Recovery: Most patients achieve sharp, stable vision within 1–2 days.
Recovery & After-Care
After-Care Guidelines
- Use prescribed antibiotic and anti-inflammatory eye drops as directed.
- Avoid eye rubbing, swimming, or high-impact activities for at least 2 weeks.
- Wear sunglasses outdoors to reduce light sensitivity.
- Attend all scheduled follow-up visits to ensure stable intraocular pressure and lens position.
Recovery Timeline
- Day 1–2: Clear vision; slight glare or halo possible.
- Week 1: Eyes adapt to the new lens; dryness minimal.
- Weeks 2–4: Stable vision; comfort and clarity improve.
- 1–3 Months: Final vision optimization and vault stabilization achieved.
Results & Longevity
Expected Results
- Crystal-clear vision at all distances.
- Enhanced contrast and night vision quality.
- Reversible and upgradeable vision correction.
- Freedom from glasses and contact lenses for most patients.
Longevity
The EVO ICL is designed to provide long-term correction for 10–20 years or more.
Results remain stable, and the lens can be safely removed or replaced if vision needs evolve.
Korean studies report over 98% patient satisfaction, with minimal regression and excellent clarity over decades.
Why Korea Is a Top Destination
Korea is a global leader in EVO ICL innovation and biometric implant precision, attracting international patients seeking the highest standards of care.
- Next-Generation Technology: Advanced AI and micro-incision lens insertion systems.
- Globally Recognized Surgeons: Korean specialists are pioneers in ICL implantation research.
- Patient-Centric Care: Multilingual support and personalized follow-up programs.
- Regenerative Recovery Protocols: Use of biologic and oxygen therapies for rapid healing.
- Affordable Premium Quality: 30–50% lower cost than comparable Western procedures.
Unique Korean Methods & Technology
- AI Biometric Lens Planning Systems
- Femtosecond Micro-Incision Implantation
- Vault Optimization & Depth Mapping
- Collamer Lens with UV-Blocking Technology
- Oxygen-Enhanced Regenerative Therapy
- Endothelial Protection Protocols
- 3D Anterior Chamber Imaging & Tracking
These innovations ensure that Advanced EVO ICL Vision Correction in Korea offers unmatched visual performance, safety, and comfort for patients worldwide.
Cost Range
| Treatment Package | Price (KRW) | Approx. USD | Inclusions |
|---|---|---|---|
| Standard ICL Surgery | ₩5,000,000 – ₩7,000,000 per eye | ~$3,500 – $5,000 | Basic EVO ICL implantation and follow-up care. |
| Advanced EVO ICL Vision Correction | ₩7,000,000 – ₩9,000,000 per eye | ~$5,000 – $6,500 | AI-based biometric planning, advanced collamer lenses, and regenerative aftercare. |
| Premium EVO ICL Package | ₩9,000,000 – ₩10,500,000+ per eye | ~$6,500 – $7,500+ | Premium toric or presbyopia-correcting ICLs, full diagnostics, and luxury aftercare services. |
Prices vary based on the lens model, surgeon expertise, and post-operative care programs.
Popular Clinics in Korea
- B&VIIT Eye Clinic (Gangnam): Pioneer in EVO ICL lens implantation with AI-assisted planning.
- Dream Eye Center (Seoul): Specializes in high-myopia ICL surgery and regenerative ocular recovery.
- BGN Eye Clinic (Busan & Seoul): International center for advanced collamer lens vision correction.
- Glory Seoul Eye Clinic: Offers toric ICLs and biologic healing protocols for superior clarity.
